INTELLIPHARMACEUTICS INTERNA (IPCI.CA) Stock Price & Overview
TSX:IPCI • CA4581733090
Current stock price
The current stock price of IPCI.CA is 0.08 CAD. Today IPCI.CA is down by -11.11%. In the past month the price increased by 6.67%. In the past year, price decreased by -30.43%.
IPCI.CA Key Statistics
- Market Cap
- 2.8M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.13
- Dividend Yield
- N/A
IPCI.CA Stock Performance
IPCI.CA Stock Chart
IPCI.CA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to IPCI.CA. When comparing the yearly performance of all stocks, IPCI.CA is a bad performer in the overall market: 74.87% of all stocks are doing better.
IPCI.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to IPCI.CA. Both the profitability and financial health of IPCI.CA have multiple concerns.
IPCI.CA Earnings
IPCI.CA Forecast & Estimates
IPCI.CA Groups
Sector & Classification
IPCI.CA Financial Highlights
Over the last trailing twelve months IPCI.CA reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 20.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -202.69% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
IPCI.CA Ownership
IPCI.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.16 | 2.564B | ||
| CRON | CRONOS GROUP INC | 38.01 | 1.277B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.063B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.53 | 948.372M | ||
| GUD | KNIGHT THERAPEUTICS INC | 131.32 | 621.999M | ||
| WEED | CANOPY GROWTH CORP | N/A | 565.768M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 20.25 | 422.176M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 414.781M | ||
| TSND | TERRASCEND CORP | N/A | 353.419M | ||
| HITI | HIGH TIDE INC | 10.22 | 279.49M | ||
| ACB | AURORA CANNABIS INC | 57.55 | 263.702M | ||
| OGI | ORGANIGRAM GLOBAL INC | 27.87 | 256.747M | ||
| RX | BIOSYENT INC | 17.47 | 177.94M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About IPCI.CA
Company Profile
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The company is headquartered in Etobicoke, Ontario. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. The company has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract (GIT), diabetes and pain. Its product portfolio includes Oxycodone Hydrochloride ER, Regabatin, Dexmethylphenidate ER, Metformin ER, Venlafaxine ER, Pantoprazole ER, Quetiapine ER, Lamotrigine ER, Levetiracetam ER, Desvenlafaxine ER, Ranolazine ER, and Carvedilol ER. Its product portfolio includes both new products and controlled-release generic products. The company also provides analytical services.
Company Info
IPO: 1999-07-22
INTELLIPHARMACEUTICS INTERNA
30 Worcester Rd
Etobicoke ONTARIO M9W 5X2 CA
CEO: Isa Odidi
Employees: 0
Phone: 14167983001
INTELLIPHARMACEUTICS INTERNA / IPCI.CA FAQ
What does IPCI do?
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The company is headquartered in Etobicoke, Ontario. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. The company has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract (GIT), diabetes and pain. Its product portfolio includes Oxycodone Hydrochloride ER, Regabatin, Dexmethylphenidate ER, Metformin ER, Venlafaxine ER, Pantoprazole ER, Quetiapine ER, Lamotrigine ER, Levetiracetam ER, Desvenlafaxine ER, Ranolazine ER, and Carvedilol ER. Its product portfolio includes both new products and controlled-release generic products. The company also provides analytical services.
What is the stock price of INTELLIPHARMACEUTICS INTERNA today?
The current stock price of IPCI.CA is 0.08 CAD. The price decreased by -11.11% in the last trading session.
Does IPCI stock pay dividends?
IPCI.CA does not pay a dividend.
How is the ChartMill rating for INTELLIPHARMACEUTICS INTERNA?
IPCI.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the market cap for INTELLIPHARMACEUTICS INTERNA?
INTELLIPHARMACEUTICS INTERNA (IPCI.CA) has a market capitalization of 2.80M CAD. This makes IPCI.CA a Nano Cap stock.